Asia Pacific High-throughput Genomic Screening For Preventive Healthcare Market Size & Outlook
Related Markets
Asia Pacific high-throughput genomic screening for preventive healthcare market highlights
- The Asia Pacific high-throughput genomic screening for preventive healthcare market generated a revenue of USD 153.5 million in 2025.
- The market is expected to grow at a CAGR of 13.3% from 2026 to 2033.
- In terms of segment, non-invasive prenatal testing (nipt) was the largest revenue generating test type in 2025.
- Pharmacogenomic Testing is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2026 to 2033.
Asia Pacific data book summary
| Market revenue in 2025 | USD 153.5 million |
| Market revenue in 2033 | USD 412.2 million |
| Growth rate | 13.3% (CAGR from 2026 to 2033) |
| Largest segment | Non-invasive prenatal testing (nipt) |
| Fastest growing segment | Pharmacogenomic Testing |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Carrier Screening, Predictive / Presymptomatic Testing, Non-Invasive Prenatal Testing (NIPT), Preimplantation Genetic Testing (PGT), Newborn Screening, Pharmacogenomic Testing, Others Test Type |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 18.1% of the global high-throughput genomic screening for preventive healthcare market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 412.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
High-Throughput Genomic Screening for Preventive Healthcare Market Scope
High-Throughput Genomic Screening for Preventive Healthcare Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BGI Group | View profile | 5001-10000 | Shenzhen, Guangdong, China, Asia | https://www.genomics.cn/ |
| 10x Genomics Inc Ordinary Shares - Class A | View profile | 1259 | 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588 | https://www.10xgenomics.com |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | https://www.23andme.com |
| Pacific Biosciences of California Inc | View profile | 796 | 1305 O’Brien Drive, Menlo Park, CA, United States, 94025 | https://www.pacb.com |
| Fulgent Genetics Inc | View profile | 1012 | 4399 Santa Anita Avenue, El Monte, CA, United States, 91731 | https://www.fulgentgenetics.com |
| Natera Inc | View profile | 3293 | 13011 McCallen Pass, Building A Suite 100, Austin, TX, United States, 78753 | https://www.natera.com |
| Exact Sciences Corp | View profile | 6600 | 5505 Endeavor Lane, Madison, WI, United States, 53719 | https://www.exactsciences.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Asia Pacific high-throughput genomic screening for preventive healthcare market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high-throughput genomic screening for preventive healthcare market will help companies and investors design strategic landscapes.
Non-invasive prenatal testing (nipt) was the largest segment with a revenue share of 34.07% in 2025. Horizon Databook has segmented the Asia Pacific high-throughput genomic screening for preventive healthcare market based on carrier screening, predictive / presymptomatic testing, non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), newborn screening, pharmacogenomic testing, others test type covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to Asia Pacific high-throughput genomic screening for preventive healthcare market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific high-throughput genomic screening for preventive healthcare market databook
-
Our clientele includes a mix of high-throughput genomic screening for preventive healthcare market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific high-throughput genomic screening for preventive healthcare market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific high-throughput genomic screening for preventive healthcare market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific high-throughput genomic screening for preventive healthcare market size, by country, 2021-2033 (US$M)
Asia Pacific High-Throughput Genomic Screening for Preventive Healthcare Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
